State Street’s Neuronetics STIM Stock Holding History

State Street’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$377K	Sell	290,299 -552,248	-66%	-$804K	﹤0.01%	3663
2026 Q1	$1.22M	Buy	842,547 +258,380	+44%	+$410K	﹤0.01%	3440
2025 Q4	$806K	Sell	584,167 -3,466	-0.6%	-$7.25K	﹤0.01%	3573
2025 Q3	$1.6M	Buy	587,633 +159,747	+37%	+$568K	﹤0.01%	3405
2025 Q2	$1.49M	Buy	427,886 +308,287	+258%	+$1.22M	﹤0.01%	3395
2025 Q1	$440K	Buy	119,599 +17,500	+17%	+$63.9K	﹤0.01%	3623
2024 Q4	$164K	Hold	102,099	–	–	﹤0.01%	3892
2024 Q3	$77.6K	Hold	102,099	–	–	﹤0.01%	4026
2024 Q2	$184K	Hold	102,099	–	–	﹤0.01%	3848
2024 Q1	$486K	Hold	102,099	–	–	﹤0.01%	3657
2023 Q4	$296K	Hold	102,099	–	–	﹤0.01%	3785
2023 Q3	$138K	Hold	102,099	–	–	﹤0.01%	4029
2023 Q2	$220K	Hold	102,099	–	–	﹤0.01%	3978
2023 Q1	$297K	Buy	102,099 +11,800	+13%	+$59.5K	﹤0.01%	3930
2022 Q4	$620K	Hold	90,299	–	–	﹤0.01%	3691
2022 Q3	$287K	Hold	90,299	–	–	﹤0.01%	3983
2022 Q2	$290K	Sell	90,299 -334,036	-79%	-$970K	﹤0.01%	4044
2022 Q1	$1.29M	Buy	424,335 +7,175	+2%	+$24.3K	﹤0.01%	3728
2021 Q4	$1.86M	Buy	417,160 +17,814	+4%	+$87.2K	﹤0.01%	3658
2021 Q3	$2.62M	Buy	399,346 +19,510	+5%	+$187K	﹤0.01%	3537
2021 Q2	$6.08M	Buy	+379,836	New	+$5.25M	﹤0.01%	3148
2020 Q2	–	Sell	-231,969	Closed	-$438K	–	3855
2020 Q1	$438K	Buy	231,969 +18,953	+9%	+$59.3K	﹤0.01%	3473
2019 Q4	$956K	Buy	213,016 +7,055	+3%	+$43.8K	﹤0.01%	3418
2019 Q3	$1.71M	Sell	205,961 -558	-0.3%	-$6.1K	﹤0.01%	3269
2019 Q2	$2.58M	Buy	206,519 +97,284	+89%	+$1.37M	﹤0.01%	3139
2019 Q1	$1.67M	Buy	109,235 +22,609	+26%	+$374K	﹤0.01%	3216
2018 Q4	$1.68M	Buy	86,626 +16,897	+24%	+$371K	﹤0.01%	3184
2018 Q3	$2.23M	Buy	+69,729	New	+$2.12M	﹤0.01%	3208

Other funds holding STIM

MAM

Madryn Asset Management New York $36.9M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street's STIM Position: Q2 2026 in Review

State Street reduced its Neuronetics (STIM) stake by 66% in Q2 2026, selling an estimated $804K and leaving 290,299 shares worth $377K. The position accounts for ﹤0.01% of the portfolio, ranked #3663.

State Street first reported a position in STIM in Q3 2018 and has held it in 28 quarters since. The position peaked at $6.08M in Q2 2021. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

State Street held 290,299 shares of Neuronetics worth $377K as of Q2 2026.
State Street sold 552,248 Neuronetics shares in Q2 2026, an estimated $804K.
Neuronetics made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3663 holding.
State Street first reported a position in Neuronetics in Q3 2018 and has held it in 28 quarters since.
State Street's Neuronetics position peaked at $6.08M in Q2 2021.
87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.